Idexx Laboratories (IDXX) Gains from Sales and Divestitures (2016 - 2017)
Historic Gains from Sales and Divestitures for Idexx Laboratories (IDXX) over the last 6 years, with Q4 2017 value amounting to $155000.0.
- Idexx Laboratories' Gains from Sales and Divestitures fell 882.35% to $155000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $155000.0, marking a year-over-year decrease of 882.35%. This contributed to the annual value of $155000.0 for FY2017, which is 882.35% down from last year.
- According to the latest figures from Q4 2017, Idexx Laboratories' Gains from Sales and Divestitures is $155000.0, which was down 882.35% from $170000.0 recorded in Q4 2016.
- In the past 5 years, Idexx Laboratories' Gains from Sales and Divestitures registered a high of $170000.0 during Q4 2016, and its lowest value of $122000.0 during Q4 2014.
- Its 4-year average for Gains from Sales and Divestitures is $146500.0, with a median of $147000.0 in 2013.
- As far as peak fluctuations go, Idexx Laboratories' Gains from Sales and Divestitures crashed by 794.7% in 2013, and later tumbled by 1223.02% in 2014.
- Quarter analysis of 4 years shows Idexx Laboratories' Gains from Sales and Divestitures stood at $139000.0 in 2013, then fell by 12.23% to $122000.0 in 2014, then surged by 39.34% to $170000.0 in 2016, then dropped by 8.82% to $155000.0 in 2017.
- Its Gains from Sales and Divestitures stands at $155000.0 for Q4 2017, versus $170000.0 for Q4 2016 and $122000.0 for Q4 2014.